Insomnia Formula
Natural health product licensed in Canada
- Other names
- Super Sleep
- Licence holder
- Natural Factors Nutritional Products Limited
- NPN or DIN-HM
- 80072694
- Status
- Active licence
- Licence date
- 23 September 2016
- Revision date
- 17 January 2017
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Scutellaria lateriflora Source : Sommité Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 60 mg | 15 mg | Not calculated |
| Tilia cordata Source : Fleur Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 37.5 mg | 7.5 mg | Not calculated |
| L-5-hydroxytryptophane Source : Griffonia simplicifolia, graine | 15 mg | Not calculated |
| L-5-hydroxytryptophane Source : 5-HTP | 15 mg | Not calculated |
| L-théanine Source : L-Théanine | 100 mg | Not calculated |
| N-[2-(5-méthoxy-1H-indol-3-yl)éthyl]acétamide Source : Mélatonine | 5 mg | Not calculated |
| Passiflora incarnata Source : Sommité Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 140 mg | 35 mg | Not calculated |
| Eschscholzia californica Source : Sommité Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 100 mg | 25 mg | Not calculated |
Non-medicinal ingredients
Silice, Croscarmellose, Fruit de Crataegus monogyna, Silicate de magnésium, Stéarate de magnésium, Phosphate de calcium dibasique dihydraté, Microcrystalline cellulose, Acide stéarique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Comprimé | 1 Tous les jours |
| Adultes | Not specified | minimum: 1 Comprimé ; maximum: 2 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Helps to temporarily promote relaxation. Helps increase the total sleep time (aspect of sleep quality) in people suffering from sleep restriction or altered sleep schedule, e.g. shift-work and jet lag. Helps to reduce the time it takes to fall asleep (sleep onset latency aspect of sleep quality) in people with delayed sleep phase disorder. Helps re-set the body¿s sleep-wake cycle (aspect of the circadian rhythm).Traditionally used in Herbal Medicine as a sleep aid (in cases of restlessness or insomnia due to mental stress). Traditionally used in Herbal Medicine as a mild sedative and/or sleep aid (hypnotic). Traditionally used in Herbal Medicine as an analgesic.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner if symptoms persist or worsen. Consult a health care practitioner prior to use if you are taking carbidopa or drugs/supplements with serotonergic activity. These may include, but are not limited to, L-tryptophan, S-adenosylmethionine (SAMe), St. John¿s wort, antidepressants, pain killers, over the counter cough and cold medication containing dextromethorphan, anti-nausea medication and anti-migraine medication. Discontinue use and consult a health care practitioner if you show signs of weakness, oral ulcers, or abdominal pain accompanied by severe muscle pain or if you experience skin changes. Consumption with alcohol, other medications or natural health products with sedative and/or analgesic properties is not recommended. If you are taking one of the following medications, consult a health care practitioner prior to use: anticoagulant, anticonvulsant, blood pressure medications, immunosuppressive medications, sedative, hypnotic or psychotropic medications, or steroids. If you have one of the following conditions, consult a health care practitioner prior to use: asthma, cardiovascular disease, chronic kidney disease, depression, diabetes or hypoglycaemia, hormonal disorder, immune system disease, liver disease, migraine, or seizure disorders. Consult a health care practitioner if sleeplessness persists continuously for more than 3 weeks (chronic insomnia). Do not use if you have scleroderma. If you are pregnant or breastfeeding, do not use this product. Some people may experience drowsiness. Exercise caution if operating heavy machinery, driving a motor vehicle or involved in activities requiring mental alertness. Some people may experience diarrhea, nausea, vomiting and abdominal pain. Mild gastrointestinal symptoms (nausea, vomiting, or cramping) have been known to occur in which case, discontinue use. Rare allergic reactions have been known to occur in which case, discontinue use. Hypersensitivity (e.g. allergy) has been known to occur; in which case, discontinue use. Keep out of reach of children.
Source
Official Health Canada record, licence 80072694
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2017. Photograph the packaging to check whether it has changed. Photograph the packaging